Aarey Drugs & Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: AAREYDRUGS BSE: 524412

About Aarey Drugs & Pharmaceuticals Limited

No company profile on record yet.

Key facts

BSE symbol524412
NSE symbolAAREYDRUGS
ISININE198H01019
CINL99999MH1990PLC056538
Listing date6 Aug 2021
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorAkshita Shetty (Akshita Shetty)
Registered officeE-34, M.I.D.C., Tarapur, Boisar, Thane - 401506, Maharashtra, India
Registrar & transfer agentMUFG Intime India Private Limited C-101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, Maharashtra, India.

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)478†—403†70†495†
Net profit44508

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Mihir R GhataliaExecutive DirectorJune 30, 2026
Nimit R GhataliaExecutive DirectorJune 30, 2026
Anil MandalIndependent DirectorJune 30, 2026
Chetan K MehtaIndependent DirectorJune 30, 2026
Lalit TulsianiIndependent DirectorJune 30, 2026
Bina GhataliaNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.